"O-I Glass Agrees to Divest Its Australia and New Zealand Business Unit"
about O-I Glass, Inc.
Notified: 16:24 EDT at $9.20
"The New England Journal of Medicine Publishes Results from Positive Phase 2b Trial of Arcutis’ ARQ-151 (Topical Roflumilast Cream) for the T..."
about Arcutis Biotherapeutics, ..
Notified: 17:06 EDT at $28.94
"Hewlett Packard Enterprise Announces European Hosted HPE GreenLake Cloud Offer with Interxion"
about Hewlett Packard Enterpris..
Notified: 04:00 EDT at $9.70
"VIAVI and VeEX Enter Into Supply Agreement and Patent License For In-Home Cable Signal Leakage Testing System"
about Viavi Solutions Inc.
Notified: 06:32 EDT at $13.28
"Aprea Therapeutics Announces Expansion of Clinical Trial Evaluating Eprenetapopt for the Front-Line Treatment of TP53 Mutant Acute Myeloid L..."
about Aprea Therapeutics, Inc.
Notified: 07:01 EDT at $29.62
"Forcura Receives Significant Growth Investment From Accel-KKR"
about Accel Entertainment, Inc.
Notified: 07:02 EDT at $9.86
"Kiniksa Announces U.S. Orphan Drug Designation for Rilonacept for the Treatment of Pericarditis"
about Kiniksa Pharmaceuticals, ..
Notified: 07:30 EDT at $22.46
"RedHill Biopharma Receives Approval for Phase 2/3 COVID-19 Study in Russia"
about Redhill Biopharma Ltd.
Notified: 08:01 EDT at $6.10
"U.S. Army Awards $21.8M Production Contract to FLIR Systems for Nerve Agent Disclosure Spray"
about FLIR Systems, Inc.
Notified: 08:01 EDT at $41.90
"Oncocyte Announces Distribution Agreement with ProGenetics Ltd, Expanding Commercial Availability of DetermaRx™ to Israel"
about OncoCyte Corp
Notified: 08:01 EDT at $1.32
"TRACON Pharmaceuticals Announces Filing of Protocol for ENVASARC Pivotal Trial with the FDA"
about TRACON Pharmaceuticals, I..
Notified: 08:15 EDT at $2.24
"Heron Therapeutics Announces Initiation of Phase 2 Clinical Study of CINVANTI® for the Treatment of COVID-19"
about Heron Therapeutics, Inc.
Notified: 08:31 EDT at $17.52
"Dynavax and Mount Sinai Announce Collaboration to Develop a Universal Influenza Vaccine Candidate with CpG 1018 Adjuvant"
about Dynavax Technologies Corp..
Notified: 08:40 EDT at $10.09
"Atossa Therapeutics Contracts for Clinical Study of AT-301 Nasal Spray, Atossa’s Second COVID-19 Therapeutic Development Program"
about Atossa Therapeutics, Inc.
Notified: 09:15 EDT at $4.48
Notice: Price change for each notified stock are being tracked by Preticks after signal notification and given stock price change analysis in this daily summary is being calculated accordingly. You can explore details for each notified signal in daily detailed performance analysis page.